Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of muscle-relaxation effects between domestic and imported rocuronium in laparoscopic surgery
ChiCTR2200056319Phase 4Not yet recruiting
- Sponsor
- Tianjin Nankai Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rocuronium (2 arms), sponsored by Tianjin Nankai Hospital. Primary endpoint: Muscle relaxation effect (onset time, 10% recovery time, recovery index). Planned start Jul 2021; status: not yet recruiting.
02
Drugs
rocuronium
Beyond the preview
Go deeper on ChiCTR2200056319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056319.